Oracle Runs

Will the results be positive?

Trial completed per ClinicalTrials.gov, but no public results posted or topline readout found in searches as of Apr 2026. Primary completion est. Feb 2026. Novartis discontinued NGI226 in portfolio review (Feb 2026), but no explicit link to negative trial results; reason unspecified. Lacks clear positive/negative framing of exact trial readout.

Will the results be positive?

Trial listed as completed with primary completion ~Feb 2026; no results posted on ClinicalTrials.gov. No public sponsor press release, readout announcement, or source clearly framing this exact Phase 2 as positive (met goals, clinically meaningful) or negative (failed, no activity). Pre-trial or general language only; no trial-specific efficacy interpretation found.

Will the results be positive?

ClinicalTrials.gov lists this study as completed but without posted results, so there is no clear public trial-specific basis yet to call the readout positive or negative.

Will the results be positive?

No trial-specific public efficacy readout was found. ClinicalTrials.gov still shows NCT05592990 as completed with 'No Results Posted,' and FDAAA TrialTracker lists no actual reporting date yet. Without a public readout clearly framing this exact Phase 2 study as positive or negative, outcome cannot be classified.

Will the results be positive?

No trial-specific public efficacy readout was found. The sponsor page describes the study and shows completion timing, but no topline or interpreted results. A trial-tracking source indicates results were still not posted/publicly due as of March 2026. Without a clear trial-specific framing, outcome cannot be classified positive or negative.